Clinical Evaluation Program of DeltaScan (ICU)

NATerminatedINTERVENTIONAL
Enrollment

3,630

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

June 1, 2021

Study Completion Date

June 29, 2021

Conditions
Delirium
Interventions
OTHER

Spot monitoring device, excl. Sham

o During the control phase the 'care as usual' regarding delirium screening is studied. During the intervention phase the DeltaScan will be studied as screening method for delirium. o During the intervention phase the DeltaScan will be used on the exact same moments, i.e. same time and same amount of measures per day, as the screening methods used in the 'care as usual'.

Trial Locations (1)

Postbus 85500

UMC Utrecht, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

collaborator

KU Leuven

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Prolira

INDUSTRY

collaborator

Factory CRO

INDUSTRY

collaborator

Implementation IQ

UNKNOWN

collaborator

European Union

OTHER

lead

UMC Utrecht

OTHER